Literature DB >> 3571980

cDNA cloning and sequencing reveals that the electrophoretically constant DR beta 2 molecules, as well as the variable DR beta 1 molecules, from HLA-DR2 subtypes have different amino acid sequences including a hypervariable region for a functionally important epitope.

S K Wu, T Yabe, M Madden, T L Saunders, F H Bach.   

Abstract

Two-dimensional gel electrophoresis (2D-PAGE) of DR molecules from three different Dw subtypes (Dw2, Dw12, and FJO) of the HLA-DR2 haplotype reveals that at least two DR beta genes are expressed. Protein mixing experiments demonstrate that one of the two expressed DR beta molecules is electrophoretically variable (referred to as DR beta 1), and the other (DR beta 2) migrates constantly among DR2 subtypes. We have constructed cDNA libraries from Dw12 and FJO homozygous typing cells (HTC DHO for Dw12 and HTC FJO for FJO) and isolated DR beta cDNA clones. Four of these clones (FJO-13, DHO-8, FJO-6, and DHO-7) were sequenced, and the deduced amino acid sequences were compared with each other and with two published amino acid sequences for the DR beta molecules derived from a DR2-Dw2HTC. Prediction of the migration patterns on 2D-PAGE from the amino acid sequences of these and other DR beta molecules allows the tentative designation of the two full-length cDNA (DHO-8 and FJO-13) as coding for DR beta 2 molecules and the other two cDNA (DHO-7 and FJO-6) for DR beta 1 molecules. Amino acid sequence comparisons also show that the constantly migrating DR beta 2 molecules, as well as the electrophoretically variable DR beta 1 molecules, from Dw2, Dw12, and FJO have different primary amino acid sequences, including a clustered difference in the third hypervariable region of the polymorphic first domain.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3571980

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

Review 1.  Evolution of HLA class-II genes and haplotypes.

Authors:  J Silver
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

Review 2.  The structural basis of alloreactivity.

Authors:  R Lechler; G Lombardi
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

3.  Two distinct subtypes of the HLA-DRw12 haplotypes in the Japanese population detected by nucleotide sequence analysis and oligonucleotide genotyping.

Authors:  A Abe; I Ito; M Ohkubo; T Kaneko; K Ito; H Kato; N Kashiwagi; F Obata
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

4.  Primate DRB6 pseudogenes: clue to the evolutionary origin of the HLA-DR2 haplotype.

Authors:  F Figueroa; C O'hUigin; H Inoki; J Klein
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

5.  MHC class II sequences of an HLA-DR2 narcoleptic.

Authors:  C B Lock; A K So; K I Welsh; J D Parkes; J Trowsdale
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

6.  Analysis of HLA-DR glycoproteins by DNA-mediated gene transfer. Definition of DR2 beta gene products and antigen presentation to T cell clones from leprosy patients.

Authors:  D Wilkinson; R R de Vries; J A Madrigal; C B Lock; J P Morgenstern; J Trowsdale; D M Altmann
Journal:  J Exp Med       Date:  1988-04-01       Impact factor: 14.307

7.  Antibiotic-refractory Lyme arthritis is associated with HLA-DR molecules that bind a Borrelia burgdorferi peptide.

Authors:  Allen C Steere; William Klitz; Elise E Drouin; Ben A Falk; William W Kwok; Gerald T Nepom; Lee Ann Baxter-Lowe
Journal:  J Exp Med       Date:  2006-04-03       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.